Clinical trial of efficacy and safety as a pilot study in pachydermoperiostosis
Not Applicable
- Conditions
- pachydermoperiostosis
- Registration Number
- JPRN-UMIN000022397
- Lead Sponsor
- ational Center for Child Health and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who met the following conditions were excluded: (1)allergy to Medicine A, (2)history of asthma, (3)history of gastrointestinal ulcer or bleeding, (4)renal diseases (serum creatinine concentration more than 1.2 mg/dl, including having a history of dialysis), (5)liver dysfunction (serum alanine or aspartate transaminase concentrations more than 3 times the upper limit of normal range), (6)heart failure or myocardial infarction, (7)body weight less than 40 kg.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method clinical symptoms and signs
- Secondary Outcome Measures
Name Time Method serum/urinary PGE2 content